A technology that combines transcriptomic data and AI enables a novel approach to drug discovery based on the state of cells, ...

Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...

BostonGene, developer of the leading AI foundation model for cancer and the immune system, announced its participation at the 21 st Annual Industry/Academia Precision Oncology & RadMed Symposium, ...

What single change could most accelerate progress across the field? We asked leading researchers, innovators and policy ...

The integration of proteomics and metabolomics in ADHD research is crucial for developing objective diagnostic tools and ...

This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...

Blackcurrant, a berry crop prized for its vitamin C and antioxidant content, faces severe yield losses when exposed to ...

Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and ...